Form 4 for GKOS GLAUKOS Corp
Accepted 2024-02-27 00:00:00 ET · period of report 2023-02-23 · accession 0001415889-24-005638 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-27 | 2024-02-23 | GKOS | Gilliam Joseph E | Pres, COO | S - Sale+OE | $92.14 | -140.2K | 102.5K | -58% | -$12.92M |
| DM | 2024-02-27 | 2024-02-23 | GKOS | Gilliam Joseph E | Pres, COO | M - OptEx | $39.82 | +118.8K | 238.6K | +99% | +$4.73M |
| DM | 2024-02-27 | 2024-02-23 | GKOS | Gilliam Joseph E | Pres, COO | M - OptEx | $0.00 | -118.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-23 | S | D | 4,092 | $93.05 | 98,388 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $92.80 to $93.45. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F1) Includes 81,885 restricted stock units that have not yet vested or been delivered to the Reporting Person. |
| 2 | Common | Common Stock | 2024-02-23 | M | A | 26,671 | $39.10 | 146,473 | D | — | — | (F1) Includes 81,885 restricted stock units that have not yet vested or been delivered to the Reporting Person. |
| 3 | Common | Common Stock | 2024-02-23 | M | A | 74,425 | $41.69 | 220,898 | D | — | — | (F1) Includes 81,885 restricted stock units that have not yet vested or been delivered to the Reporting Person. |
| 4 | Common | Common Stock | 2024-02-23 | M | A | 13,128 | $30.92 | 234,026 | D | — | — | (F1) Includes 81,885 restricted stock units that have not yet vested or been delivered to the Reporting Person. |
| 5 | Common | Common Stock | 2024-02-23 | M | A | 4,607 | $39.10 | 238,633 | D | — | — | (F1) Includes 81,885 restricted stock units that have not yet vested or been delivered to the Reporting Person. |
| 6 | Common | Common Stock | 2024-02-23 | S | D | 21,414 | $90.94 | 217,219 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $90.37 to $91.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F1) Includes 81,885 restricted stock units that have not yet vested or been delivered to the Reporting Person. |
| 7 | Common | Common Stock | 2024-02-23 | S | D | 114,739 | $92.33 | 102,480 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $91.79 to $92.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F1) Includes 81,885 restricted stock units that have not yet vested or been delivered to the Reporting Person. |
| 8 | Derivative | Stock Option (Right to Buy) | 2024-02-23 | M | D | 26,671 | $0.00 | 1,053 | D | $39.10 · — to 2030-03-12 | 26,671 Common Stock | (F9) The amount reported reflects an adjustment of 5,000 shares underlying a stock option grant reported as exercised on a Form 4 filed with the Securities and Exchange Commission on February 12, 2024. The exercise was inadvertently attributed to the stock option grant issued on 3/12/2020 and subject to a time-based vesting schedule, but should have been attributed to the stock option grant issued on 3/12/2020 and subject to performance-based vesting requirements. In addition, the amount reported takes into account a reconciliation adjustment to reflect the Reporting Person's economic interest in the shares underlying this stock option grant to comply with the terms of a domestic relations order issued in connection with a marital dissolution. (F8) This option was granted on March 12, 2020 and has a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vests in equal monthly installments for 36 months thereafter, such that the stock option vests in full on the four-year anniversary of the grant date. |
| 9 | Derivative | Stock Option (Right to Buy) | 2024-02-23 | M | D | 13,128 | $0.00 | 0 | D | $30.92 · — to 2028-03-14 | 13,128 Common Stock | (F6) The amount reported takes into account a reconciliation adjustment to reflect the Reporting Person's economic interest in the shares underlying this stock option grant to comply with the terms of a domestic relations order issued in connection with a marital dissolution. (F7) This option was granted on March 14, 2018 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date. |
| 10 | Derivative | Stock Option (Right to Buy) | 2024-02-23 | M | D | 74,425 | $0.00 | 43,929 | D | $41.69 · — to 2027-05-05 | 74,425 Common Stock | (F6) The amount reported takes into account a reconciliation adjustment to reflect the Reporting Person's economic interest in the shares underlying this stock option grant to comply with the terms of a domestic relations order issued in connection with a marital dissolution. (F5) This option was granted on May 5, 2017 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date. |
| 11 | Derivative | Stock Option (Right to Buy) | 2024-02-23 | M | D | 4,607 | $0.00 | 0 | D | $39.10 · — to 2030-03-12 | 4,607 Common Stock | (F11) The amount reported reflects an adjustment of 5,000 shares underlying a stock option grant reported as exercised on a Form 4 filed with the Securities and Exchange Commission on February 12, 2024. The exercise was inadvertently attributed to the stock option grant issued on 3/12/2020 and subject to a time-based vesting schedule, but should have been attributed to the stock option grant issued on 3/12/2020 and subject to performance-based vesting requirements. (F10) Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 12, 2020, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. |